PW
AUPH icon

Pandora Wealth’s Aurinia Pharmaceuticals AUPH Stock Holding History

Pandora Wealth’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.2K Hold
75
– – ﹤0.01% 215
2025
Q3 		$829 Hold
75
– – ﹤0.01% 217
2025
Q2 		$635 Hold
75
– – ﹤0.01% 273
2025
Q1 		$603 Buy
+75
New +$608 ﹤0.01% 246

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pandora Wealth's AUPH Position: Q4 2025 in Review

Pandora Wealth held its Aurinia Pharmaceuticals (AUPH) position steady in Q4 2025 at 75 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #215.

Pandora Wealth first reported a position in AUPH in Q1 2025 and has held it in 4 quarters since. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

  • Pandora Wealth held 75 shares of Aurinia Pharmaceuticals worth $1.2K as of Q4 2025.
  • Pandora Wealth left its Aurinia Pharmaceuticals share count unchanged in Q4 2025.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Pandora Wealth's portfolio in Q4 2025, its #215 holding.
  • Pandora Wealth first reported a position in Aurinia Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Pandora Wealth's 13F filing for Q4 2025, filed 4 Feb 2026.